Prostate Therapy Hikes Colon CA Risk (CME/CE)
(MedPage Today) — Patients on long-term androgen deprivation therapy (ADT) for prostate cancer had a 30% to 40% increased risk of colorectal cancer compared with patients who did not receive ADT, analysis of an NCI database showed.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com